94 related articles for article (PubMed ID: 16503420)
61. Synthetic approaches to vaccines for infectious and autoimmune diseases.
Sela M; Arnon R
Vaccine; 1992; 10(14):991-9. PubMed ID: 1471429
[TBL] [Abstract][Full Text] [Related]
62. New approach to immunotherapy against organ-specific autoimmune diseases with T cell receptor and chemokine receptor DNA vaccines.
Matsumoto Y
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Mar; 5(1):73-7. PubMed ID: 15777206
[TBL] [Abstract][Full Text] [Related]
63. A study of acquired resistance to experimental allergic encephalomyelitis and of the development of the encephalitogenic brain-substance during ontogeny.
SVET-MOLDAVSKAYA IA; SVET-MOLDAVSKY GI
Acta Virol; 1959 Jan; 3(1):1-8. PubMed ID: 13626647
[No Abstract] [Full Text] [Related]
64. Post-vaccinial encephalomyelitis.
SPILLANE JD
Proc R Soc Med; 1963 Jul; 56(7):542-5. PubMed ID: 13990137
[No Abstract] [Full Text] [Related]
65. Vaccination with single chain antigen receptors for islet-derived peptides presented on I-A(g7) delays diabetes in NOD mice by inducing anergy in self-reactiveT-cells.
Gurr W; Shaw M; Herzog RI; Li Y; Sherwin R
PLoS One; 2013; 8(7):e69464. PubMed ID: 23894487
[TBL] [Abstract][Full Text] [Related]
66. Vaccination with BV8S2 protein amplifies TCR-specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice.
Offner H; Adlard K; Bebo BF; Schuster J; Burrows GG; Buenafe AC; Vandenbark AA
J Immunol; 1998 Sep; 161(5):2178-86. PubMed ID: 9725209
[TBL] [Abstract][Full Text] [Related]
67. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
Matejuk A; Buenafe AC; Dwyer J; Ito A; Silverman M; Zamora A; Subramanian S; Vandenbark AA; Offner H
J Neurosci Res; 2003 Jan; 71(1):89-103. PubMed ID: 12478617
[TBL] [Abstract][Full Text] [Related]
68. A chimeric TCR-beta chain confers increased susceptibility to EAE.
Petersen TR; Lata R; Spittle E; Bäckström BT
Mol Immunol; 2007 Jul; 44(14):3473-81. PubMed ID: 17481734
[TBL] [Abstract][Full Text] [Related]
69. A novel protective model against experimental allergic encephalomyelitis in mice expressing a transgenic TCR-specific for myelin oligodendrocyte glycoprotein.
Mendel I; Natarajan K; Ben-Nun A; Shevach EM
J Neuroimmunol; 2004 Apr; 149(1-2):10-21. PubMed ID: 15020060
[TBL] [Abstract][Full Text] [Related]
70. T cell receptor peptide therapy for autoimmune encephalomyelitis: stronger immunization is necessary for effective vaccination.
Matsumoto Y; Tsuchida M; Hanawa H; Abo T
Cell Immunol; 1994 Feb; 153(2):468-78. PubMed ID: 8118876
[TBL] [Abstract][Full Text] [Related]
71. TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis.
Aroeira LS
Clin Immunol; 2006 Jun; 119(3):252-60. PubMed ID: 16503420
[TBL] [Abstract][Full Text] [Related]
72. Protection from autoimmunity by DNA vaccination against T-cell receptor.
Buch T; Waisman A
Methods Mol Med; 2006; 127():269-80. PubMed ID: 16988460
[TBL] [Abstract][Full Text] [Related]
73. Immunoregulation by Vbeta specific antibodies in myasthenia gravis: mining physiological T cell homeostasis for TCR specific therapy.
Jambou F; Cohen-Kaminsky S
Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):181-92. PubMed ID: 12887101
[TBL] [Abstract][Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
